Anti-biofouling therapeutic nanoparticles with removable shell and highly efficient internalization by cancer cells

2019 ◽  
Vol 7 (1) ◽  
pp. 336-346
Author(s):  
Dong Chen ◽  
Huangyong Jiang ◽  
Dongbo Guo ◽  
Wumaier Yasen ◽  
Junping Ao ◽  
...  

We fabricated a novel nanomedicine possessing both anti-biofouling feature and relatively high cellular internalization.

2011 ◽  
Vol 91 (3) ◽  
pp. 613-621 ◽  
Author(s):  
Silvia Sommaruga ◽  
Alessio Lombardi ◽  
Agnese Salvadè ◽  
Serena Mazzucchelli ◽  
Fabio Corsi ◽  
...  

2011 ◽  
Vol 22 (9) ◽  
pp. 095101 ◽  
Author(s):  
Radu Marches ◽  
Carole Mikoryak ◽  
Ru-Hung Wang ◽  
Paul Pantano ◽  
Rockford K Draper ◽  
...  

2014 ◽  
Vol 2 (1) ◽  
pp. 36-51 ◽  
Author(s):  
Radhika Raveendran ◽  
C. K. S. Pillai ◽  
G. S. Bhuvaneshwar ◽  
Chandra P. Sharma

Author(s):  
Elham Kamalkazemi ◽  
Fereydoon Abedi - Gaballu ◽  
Tala Farid Mohammad Hosseini ◽  
Ali Mohammadi ◽  
Behzad Mansoori ◽  
...  

: Lipid-based nanoparticles as drug delivery carriers have been mainly used for delivery of anti-cancer therapeutic agents. Lipid-based nanoparticles, due to their smaller particle size and similarity to cell membranes, are readily internalized into cancer cells. Interestingly, cancer cells also overexpress receptors for specific ligands including folic acid, hyaluronic acid, and transferrin on their surface. This allows the use of these ligands for surface modification of the lipid-based nanoparticle. These modifications then allow the specific recognition of these ligand-coated nanoparticles by their receptors on cancer cells allowing the targeted gradual intracellular accumulation of the functionalized nanoplatforms. These interactions could eventually enhance the internalization of desired drugs via increasing ligand-receptor mediated cellular uptake of the nanoplatforms. The cellular internalization of the nanoplatforms also varies and depends on their physicochemical properties including particle size, zeta potential, and shape. The cellular uptake is also influenced by the types of ligand internalization pathway utilized by cells such as phagocytosis, macropinocytosis, and multiple endocytosis pathways. In this review, we will classify and discuss lipid based nanoparticles engineered to express specific ligands, and are recognized by their receptors on cancer cell, and their cellular internalization pathways. Moreover, the intracellular fate of nanoparticles decorated with specific ligands and the best internalization pathways (caveolae mediated endocytosis) for safe cargo delivery will be discussed.


RSC Advances ◽  
2015 ◽  
Vol 5 (115) ◽  
pp. 94855-94858 ◽  
Author(s):  
Rumei Cheng ◽  
Shengju Ou ◽  
Yexu Bu ◽  
Xuan Li ◽  
Xiaohong Liu ◽  
...  

Novel antitumor drugs, compatible with normal cells but highly toxic against cancer cells, were prepared from starch–borate–graphene oxide (SBG) nanocomposites.


Nanoscale ◽  
2014 ◽  
Vol 6 (3) ◽  
pp. 1529-1536 ◽  
Author(s):  
Moon Il Kim ◽  
Min Su Kim ◽  
Min-Ah Woo ◽  
Youngjin Ye ◽  
Kyoung Suk Kang ◽  
...  

2016 ◽  
Vol 8 (49) ◽  
pp. 33457-33463 ◽  
Author(s):  
Shuangqian Yan ◽  
Xian Zhang ◽  
Xiaofang Dai ◽  
Xiaojun Feng ◽  
Wei Du ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document